CDC AMR Challenge

The U.S. government’s Antimicrobial Resistance (AMR) Challenge is a yearlong effort to accelerate the fight against antimicrobial resistance across the globe that launched at the United Nations General Assembly in September 2018. 

 

 

New: FAQs

DASON member hospitals now have access to a regularly updated antimicrobial stewardship FAQs page
 

Learn More

Improving Patient Care and Patient Safety

DASON exists in order to help community hospitals address unnecessary antimicrobial use developing an evidence-based, state-of-the art antimicrobial stewardship network.

DASON Continuing Education Series

We are happy to announce that DASON has received approval to offer recurring continuing education programs for all of our participating hospitals!

2019 Schedule Now Available!

DASON News

Seven DASON Hospitals Listed on Georgia Honor Roll for Antibiotic Stewardship

The Georgia Honor Roll for Antibiotic Stewardship was established in 2014 by the Healthcare Associated Infections Advisory Committee, a part of the Georgia Department of Public Health. The original goal of the program was the provide an incentive for acute care facilities and critical access hospitals to engage in antimicrobial stewardship.

Read More

Experts Tackle Antibiotic Stewardship Best Practices

Libby Dodds-Ashley talks about the 2-day Antimicrobial Stewardship Research Workshop, hosted by the Society for Healthcare Epidemiology of America (SHEA), and how it brings together physicians, pharmacists, and other health professionals to learn how to study and assess the performance of antibiotic stewardship interventions. 

Read the full article from CIDRAP here

Read More

Libby Dodds Ashley Talks About the Need for New Antibiotics

Many drug companies have announced plans to stop development of antibiotics for financial reasons. In a recent article in Healio, DASON director and Society of Infectious Diseases Pharmacists President Libby Dodds Ashley spoke about the importance of continuing to develop new antibiotics.

It’s the one area that drug companies are abandoning and it’s the one drug class that will always need more drugs. ... It’s unfortunate that many companies are being forced out of that marketplace because of understandable but financial reasons.

 

Read More

The impact of an effective antimicrobial stewardship on patient safety, better patient outcomes, hospital costs, and reducing antimicrobial resistance are enormous.

—Dan Sexton, MD, Medical Director of DASON

The resources and support we have received from DASON have allowed us to move projects forward in our antimicrobial stewardship efforts much more quickly and effectively than we could ever have done on our own.

—Mary Mallory, RPh, Clinical Pharmacy Coordinator, Iredell Memorial Hospital